$8.00 per share in cash ("Tender Offer"). Celera is a healthcare business focusing on the integration of genetic testing into routine clinical care through a combination of products and services incorporating proprietary discoveries. The complaint states...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Brower Piven Files Class Action Suit Against Celera Corporation (NasdaqGS: CRA)
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account